The appearance and pricing of mitotane in China

Mitotane , also known as Mitotane in English, is a drug that has been released in China a little later than internationally. Although it has long become an important drug in the treatment of adrenocortical cancer and Cushing's syndrome globally, in our country, it did not officially debut until about 2023. This undoubtedly brings new hope to those patients with adrenocortical cancer in China who are difficult to completely treat through surgery.

Although Mitotane has been put on the shelves in China, unfortunately, it has not been included in the medical insurance system, which means that patients need to bear the cost themselves. Since new drugs have not been on the shelves for a long time, their market prices may fluctuate, so it is recommended that patients directly consult their local hospital or pharmacy for specific prices. However, judging from the current market trends, the domestic selling price of Mitotane is not low.

In the international market, consumers can choose original drugs or generic drugs. The original drug, represented by the European version, is relatively expensive, with a box selling for about more than 9,000 yuan. In contrast, foreign generic drugs, such as those from Laos, are much more affordable, costing only about one to two thousand yuan, and their efficacy is almost the same as that of the original drugs. For those patients with limited financial conditions, purchasing foreign generic drugs may alleviate some financial pressure, but the prerequisite is that the quality and legality of the source of the purchased drugs must be ensured.

Mitotane , as an effective drug for the treatment of adrenocortical cancer and Cushing's syndrome, has been marketed in China, but because it is not covered by medical insurance, the purchase cost for patients is relatively high. At present, the domestic price of a box of mitotane (mitotane) is about more than 9,000 yuan, which requires patients to pay out of their own pockets. In order to better control the disease and reduce the financial burden, patients should use medications rationally under the guidance of their doctors, and always check with local hospitals or pharmacies for the latest price information and availability. If economic conditions permit, it is also a good choice to consider purchasing more affordable generic drugs from abroad, but be sure to pay attention to the quality and legal channels of the drugs.